Sanofi exercises option on second therapeutic programme with Selecta Biosciences to develop a treatment for coeliac disease
Under the terms of an existing agreement with Selecta, Sanofi…
13 May 2015 | By Victoria White
Under the terms of an existing agreement with Selecta, Sanofi has exercised its option to an exclusive license to develop a treatment of coeliac disease...